Table 2. Dosimetric parameters for the PTV1, rectum, bladder, and femoral heads.
Mean ± SEM
|
||
---|---|---|
Parameter | Arm I | Arm II |
CTV1 volume (cm3) | 54.2 ± 3.1 | 65.0 ± 4.1 |
PTV1 volume (cm3) | 145.1 ± 5.8 | 158.4 ± 7.5 |
Rectal volume (cm3) | 58.8 ± 2.4 | 57.4 ± 2.7 |
Bladder volume (cm3) | 261.0 ± 18.8 | 254.9 ± 18.7 |
PTV1 D95% (Gy)* | 76.0 ± 0.2 | 70.4 ± 0.1 |
PTV1 mean dose (Gy)* | 81.1 ± 0.3 | 73.8 ± 1.0 |
PTV1 max dose (Gy)* | 88.4 ± 0.3 | 82.4 ± 0.3 |
PTV1 min dose (Gy)* | 62.8 ± 1.2 | 55.7 ± 1.2 |
Rectal V65/50 Gy (%)* | 11.7 ± 0.4 | 15.9 ± 0.5 |
Rectal V40/31 Gy (%)* | 28.1 ± 1.2 | 29.8 ± 0.9 |
Bladder V65/50 Gy (%)* | 16.1 ± 1.2 | 27.1 ± 1.8 |
Bladder V40/31 Gy (%)* | 34.8 ± 2.2 | 45.6 ± 2.7 |
Bladder max dose (Gy)* | 86.8 ± 0.3 | 80.6 ± 0.3 |
Rectal max dose (Gy)* | 86.4 ± 0.3 | 79.4 ± 0.3 |
Right femoral head V50/40 Gy (%)* | 1.0 ± 0.3 | 3.1 ± 0.5 |
Left femoral head V50/40 Gy (%)* | 1.4 ± 0.4 | 3.4 ± 0.5 |
Abbreviations: Arm I = conventional fraction intensity-modulated radiation therapy; Arm II = hypofractionation intensity-modulated radiation therapy; CTV = clinical tumor volume; PTV = planning target volume; D95% = dose to 95% of the volume.
p < 0.05 between groups, two-sided Wilcoxon test.